Literature DB >> 31933968

Knockdown of lncRNA XIST suppresses osteosarcoma progression by inactivating AKT/mTOR signaling pathway by sponging miR-375-3p.

Xin Sun1, Bo Wei1, Zhi-Heng Peng1, Qing-Long Fu1, Chao-Jun Wang1, Jin-Chang Zheng1, Jie-Cong Sun1.   

Abstract

BACKGROUND: Osteosarcoma (OS) is one of the most common bone tumors in adolescents and young adults. Emerging evidence suggested ncRNA (lncRNA and miRNA) are closely associated with cell progression, apoptosis and autophagy. However, the role of regulatory network between ncRNA and mRNA in OS has not been fully verified.
METHODS: lncRNA XIST, miRNA expression were detected by qRT-PCR. The protein expression of LC3, p62, AKT, p-AKT, mTOR and p-mTOR was measured by western blot. MTT assay and flow cytometry were applied to measure cell proliferation and apoptosis. Luciferase assay was used to ensure the relationship between lncRNA, miRNA and mRNA. GFP-LC3 cells were observed using fluorescence microscope.
RESULTS: XIST expression was up-regulated but miR-375-3p was down-regulated in OS tissues and cells. Luciferase assay results demonstrated that miR-375-3p was a target of XIST and mTOR was a target mRNA of miR-375-3p. In addition, knockdown of XIST and mTOR inhibited OS cell proliferation and autophagy, but induced apoptosis. Knockdown of XIST could reverse the effect of miR-375-3p inhibitor on OS cells. The effects of si-mTOR of OS cells could be reversed by silencing miR-375-3p. Moreover, knockdown of XIST inhibited AKT/mTOR signaling pathway via sponging miR-375-3p.
CONCLUSION: Knockdown of XIST inhibited cell growth and autophagy but induced cell apoptosis by suppressing the AKT/mTOR signaling pathway by sponging miR-375-3p. IJCEP
Copyright © 2019.

Entities:  

Keywords:  AKT/mTOR; Osteosarcoma; XIST; miR-375-3p

Year:  2019        PMID: 31933968

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  13 in total

1.  LncRNA XIST facilitates S1P-mediated osteoclast differentiation via interacting with FUS.

Authors:  Da-Wei Zhang; Hong-Gang Wang; Kui-Bo Zhang; Yuan-Qing Guo; Lian-Jun Yang; Hai Lv
Journal:  J Bone Miner Metab       Date:  2022-01-23       Impact factor: 2.626

2.  LINC01410 accelerated the invasion and proliferation of osteosarcoma by sponging miR-3128.

Authors:  Quanxiao Xu; Limin He; Lei Ma; Lin Fan; Lihua Yan; Xulin Zhao; Yuanyuan Li
Journal:  Aging (Albany NY)       Date:  2020-12-19       Impact factor: 5.682

3.  Downregulation of lncRNA XIST Represses Tumor Growth and Boosts Radiosensitivity of Neuroblastoma via Modulation of the miR-375/L1CAM Axis.

Authors:  Haiyan Yang; Xiao Zhang; Yuehua Zhao; GuoLi Sun; Jian Zhang; Yiwen Gao; Qian Liu; Wenhua Zhang; Hongjin Zhu
Journal:  Neurochem Res       Date:  2020-08-28       Impact factor: 3.996

4.  Development of a Machine Learning-Based Autophagy-Related lncRNA Signature to Improve Prognosis Prediction in Osteosarcoma Patients.

Authors:  Guang-Zhi Zhang; Zuo-Long Wu; Chun-Ying Li; En-Hui Ren; Wen-Hua Yuan; Ya-Jun Deng; Qi-Qi Xie
Journal:  Front Mol Biosci       Date:  2021-05-21

5.  Long non-coding RNA X-inactive specific transcript promotes osteosarcoma metastasis via modulating microRNA-758/Rab16.

Authors:  Wei Liu; Qiuping Long; Li Zhang; Dehui Zeng; Bingbing Hu; Wei Zhang; Shengyao Liu; Songyun Deng; Li Chen
Journal:  Ann Transl Med       Date:  2021-05

Review 6.  X-Inactive-Specific Transcript: Review of Its Functions in the Carcinogenesis.

Authors:  Soudeh Ghafouri-Fard; Sepideh Dashti; Molood Farsi; Mohammad Taheri; Seyed Ali Mousavinejad
Journal:  Front Cell Dev Biol       Date:  2021-06-11

Review 7.  Biological Function of Long Non-coding RNA (LncRNA) Xist.

Authors:  Wenlun Wang; Lu Min; Xinyuan Qiu; Xiaomin Wu; Chuanyang Liu; Jiaxin Ma; Dongyi Zhang; Lingyun Zhu
Journal:  Front Cell Dev Biol       Date:  2021-06-10

Review 8.  The crosstalk between lncRNAs and the Hippo signalling pathway in cancer progression.

Authors:  Chao Tu; Kexin Yang; Lu Wan; Jieyu He; Lin Qi; Wanchun Wang; Qiong Lu; Zhihong Li
Journal:  Cell Prolif       Date:  2020-08-10       Impact factor: 6.831

Review 9.  The lncRNAs at X Chromosome Inactivation Center: Not Just a Matter of Sex Dosage Compensation.

Authors:  Chiara Siniscalchi; Armando Di Palo; Aniello Russo; Nicoletta Potenza
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

10.  Arbutin suppresses osteosarcoma progression via miR-338-3p/MTHFD1L and inactivation of the AKT/mTOR pathway.

Authors:  Cheng-Qun Wang; Xiu-Mei Wang; Bing-Liang Li; Yuan-Min Zhang; Lei Wang
Journal:  FEBS Open Bio       Date:  2020-12-03       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.